A Case of Therapy-Related Acute Leukemia With Mixed Phenotype With BCR-ABL1 After Treatment of Diffuse Large B-Cell Lymphoma
Dear Editor, Although therapy-related acute leukemia (tAL) is a well-recognized clinical syndrome and is increasing owing to the prolonged survival of patients treated with chemoradiotherapy [1], tAL with mixed phenotype is extremely rare. Only four cases of tAL with mixed phenotype have been report...
Gespeichert in:
Veröffentlicht in: | Annals of laboratory medicine 2017, 37(2), , pp.166-168 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Dear Editor, Although therapy-related acute leukemia (tAL) is a well-recognized clinical syndrome and is increasing owing to the prolonged survival of patients treated with chemoradiotherapy [1], tAL with mixed phenotype is extremely rare. Only four cases of tAL with mixed phenotype have been reported worldwide; among them, only one case occurred after hematologic malignancy [2, 3]. Here, we report a rare case of tAL with mixed phenotype with BCR-ABL1 after achieving complete remission (CR) of diffuse large B-cell lymphoma (DLBCL). KCI Citation Count: 0 |
---|---|
ISSN: | 2234-3806 2234-3814 |
DOI: | 10.3343/alm.2017.37.2.166 |